University Of Chicago
Clinical trials sponsored by University Of Chicago, explained in plain language.
-
Experimental combo targets tough pancreatic tumors
Disease control Recruiting nowThis early-stage study is testing whether combining two drugs—Fulvestrant and a radioactive therapy called Lu-DOTATATE—is safe and might help control advanced pancreatic neuroendocrine tumors. The study will enroll about 25 adults whose cancer has spread and has worsened despite …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New program aims to tackle the hidden stress of diabetes care
Disease control Recruiting nowThis study is testing a new training program for primary care clinics called ARISE. The goal is to help doctors and nurses better screen for and address 'diabetes distress'—the unique emotional stress of managing the disease—in adults with type 2 diabetes. Researchers want to see…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug cocktail tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a combination of four drugs is safe and effective for people with multiple myeloma that has returned or stopped responding to standard treatments, including CAR-T cell therapy. About 83 adults whose cancer worsened after at least two prior treatment …
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for diabetics: transplanting insulin factories
Disease control Recruiting nowThis study is testing whether transplanting insulin-producing cells, called islets, from deceased donors is safe for people with type 1 diabetes who have already had a kidney transplant. The goal is to see if this procedure can help patients achieve better blood sugar control wit…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Tough-to-Treat head and neck cancers
Disease control Recruiting nowThis early-stage trial is testing a new combination of two experimental drugs, tislelizumab and pamiparib, given together with a standard course of chemotherapy and radiation. The goal is to find a safe and effective dose for people whose head and neck cancer has come back after …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can a baby aspirin save a new Mom's heart?
Disease control Recruiting nowThis study is testing if a daily low-dose aspirin pill can help prevent heart damage in women who recently had preeclampsia, a serious pregnancy complication. Researchers will check a specific blood marker (Activin A) to identify women at higher risk and then give them either asp…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Friendship as medicine: new trial tests if social support can help control HIV
Disease control Recruiting nowThis study is testing whether a single counseling session with a trusted friend or family member can help people with HIV stay on track with their medical appointments and medication. It will involve 900 people in Chicago and Alabama. The goal is to see if this social support app…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test 'Gut Bug' cocktails to help failing livers
Disease control Recruiting nowThis early-stage trial is testing whether specially designed mixtures of helpful gut bacteria are safe for people hospitalized with serious liver disease. Researchers want to see if these bacterial mixtures can restore a healthier gut environment, which is often damaged in liver …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough blood cancers: experimental combo enters human trials
Disease control Recruiting nowThis study is testing whether adding a new drug called capivasertib to standard chemotherapy works better for adults with acute leukemia or lymphoblastic lymphoma. Researchers will first find the safest dose, then test if the combination helps patients achieve remission with no d…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested in fight against tough leukemia in young adults
Disease control Recruiting nowThis early-stage study aims to find out if adding a drug called ruxolitinib to standard chemotherapy is safe and tolerable for adolescents and young adults (ages 18-40) newly diagnosed with a specific, hard-to-treat form of acute lymphoblastic leukemia (ALL). The main goal is to …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First trial tests Genetic-Guided 'Chemo Cocktail' for tough cancers
Disease control Recruiting nowThis early-stage study aims to find the safest dose of a powerful combination of five chemotherapy drugs for people with advanced cancers of the stomach, pancreas, and related areas. It uses a patient's genetic test results to personalize the dose of one key drug, hoping to reduc…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Could a common pill stop painful kidney stones?
Disease control Recruiting nowThis early study is testing if a medication called empagliflozin, usually used for diabetes and heart health, can change urine chemistry to help prevent calcium-based kidney stones from forming again. Researchers will give the drug to 32 adults with a history of these stones for …
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
MRI guides radiation to spare healthy tissue in prostate cancer treatment
Disease control Recruiting nowThis study is testing whether using MRI scans to guide radiation treatment can allow doctors to use lower overall radiation doses for prostate cancer. Researchers aim to reduce side effects like bowel problems while still effectively treating the cancer. The trial will enroll 60 …
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for Tough-to-Treat anal and rectal cancers
Disease control Recruiting nowThis study is testing whether combining two drugs, lenvatinib and pembrolizumab, can help control advanced anal or rectal cancer that has spread and is no longer responding to standard chemotherapy. It will involve about 35 adults whose cancer has progressed after initial treatme…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Common painkiller may prevent unnecessary prostate biopsies
Disease control Recruiting nowThis study is testing whether the over-the-counter anti-inflammatory drug ibuprofen can lower PSA levels in men with elevated readings. High PSA can signal prostate cancer but is often caused by harmless inflammation. Researchers want to see if reducing inflammation with ibuprofe…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors test 3-Week radiation to fight uterine cancer
Disease control Recruiting nowThis study is testing a shorter, 3-week course of pelvic radiation for women with non-metastatic uterine or cervical cancer who have had surgery. The main goal is to find out if this shorter schedule is safe and tolerable, and to see how it affects patients' quality of life, bowe…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Laughing gas could be new hope for depression
Disease control Recruiting nowThis study is testing whether nitrous oxide (commonly known as laughing gas) can help reduce symptoms of depression. Researchers will give 172 adults with major depressive disorder weekly one-hour breathing sessions of either nitrous oxide or a placebo air mixture for four weeks.…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heart rhythm hope: weight loss drug trial targets common irregular heartbeat
Disease control Recruiting nowThis study is testing if a medication called semaglutide, which is approved for weight loss, can help people with both obesity and atrial fibrillation (AFib). Researchers want to see if losing weight with this drug can reduce how often AFib occurs and its severity when used along…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First human trial launches for promising blood cancer drug duo
Disease control Recruiting nowThis early-stage study is testing a new combination of two drugs, selumetinib and azacitidine, for adults with higher-risk chronic myeloid blood cancers like myelodysplastic syndromes (MDS) and myelofibrosis. The main goal is to find the safest and most effective dose by carefull…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New study seeks better treatment clues for aggressive breast cancer
Disease control Recruiting nowThis study aims to see how well a specific chemotherapy combination works for Nigerian women with triple-negative breast cancer, a particularly aggressive form. Researchers will measure how many women have no detectable cancer after treatment and will also look for signals in the…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Getting stronger before surgery: can home exercises improve recovery for frail patients?
Disease control Recruiting nowThis study is testing a home-based exercise and education program designed to help physically frail older adults get stronger before they undergo lung surgery. The goal is to see if this 'prehab' program is practical to run and if it helps patients recover better with fewer compl…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists test faster, stronger radiation for blood cancer
Disease control Recruiting nowThis study is testing if a shorter course of radiation therapy is safe for people with multiple myeloma. Instead of the usual 2-3 weeks of daily treatments, researchers want to see if giving higher doses over just 1 to 10 days works as well and is safe. The trial will enroll 30 a…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Genetic blueprint could make chemotherapy safer and more effective
Disease control Recruiting nowThis study tests whether using patients' genetic information helps doctors personalize chemotherapy doses to reduce side effects while maintaining effectiveness. Researchers will randomly assign 860 cancer patients to either receive genetic-guided dosing or standard care. The goa…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo tested for Tough-to-Treat colon cancer
Disease control Recruiting nowThis study is testing the safety and effectiveness of combining two drugs, VS-6766 and cetuximab, for people with advanced colorectal cancer that has a specific genetic change called a KRAS mutation. The study is for people whose cancer has continued to grow despite trying standa…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Smartphone and coach team up to fight weight gain in young adults
Disease control Recruiting nowThis study is testing a 6-month program that combines personal coaching with smartphone apps and activity trackers to help young adults lose weight. Researchers want to see if this tech-supported approach is more effective than standard methods. About 140 participants will track …
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Study asks: can we stop prostate cancer drugs for good in older men?
Disease control Recruiting nowThis study is testing whether elderly men with prostate cancer who have been on long-term hormone therapy can safely stop their treatment. Researchers want to see if their bodies remain in a low-testosterone state without the medication, which could reduce side effects and health…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New combo therapy aims to shrink tough head and neck tumors
Disease control Recruiting nowThis study is testing a new treatment approach for people with a specific type of head and neck cancer that is not linked to HPV. The goal is to see if a combination of a new immunotherapy drug (volrustomig) with two standard chemotherapy drugs can shrink tumors before patients r…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental cocktail aims to battle resistant blood cancers
Disease control Recruiting nowThis early-stage study is testing whether an experimental drug called LP-118 can be safely combined with an approved leukemia drug, ponatinib, and standard chemotherapy. The goal is to find the safest and most effective dose for patients whose T-cell acute lymphoblastic leukemia …
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Spinal stimulator trial aims to ease diabetic pain and boost blood flow
Disease control Recruiting nowThis study is testing if a temporary spinal cord stimulator can help people with type 2 diabetes who have painful nerve damage in their legs. Researchers want to see if the device not only reduces pain but also improves blood circulation and artery health in the lower limbs. The …
Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Common allergy spray tested as potential early COVID-19 treatment
Disease control Recruiting nowThis study is testing whether Astepro, a common allergy nasal spray, can help control early COVID-19 infection. Researchers will give the spray or a placebo to 280 vaccinated adults who just tested positive but have only mild or no symptoms. They will measure if the spray reduces…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo therapy aims to shrink tumors, cut harsh treatment for HPV-Linked throat cancer
Disease control Recruiting nowThis study is testing whether adding two new, experimental drugs (HB-201 and HB-202) to standard chemotherapy can better shrink tumors in people with HPV16-positive throat cancer. The goal is to see if this stronger initial treatment allows doctors to safely use less radiation or…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for severe diabetes: trial tests drug to protect transplanted insulin cells
Disease control Recruiting nowThis study is testing a new drug, Tegoprubart, combined with standard medications to see if it can safely help transplanted islet cells survive and produce insulin in people with severe type 1 diabetes. The goal is to reduce or eliminate the need for insulin injections and preven…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Breakthrough study asks: can UC patients ditch their meds?
Disease control Recruiting nowThis study aims to find out if people with ulcerative colitis who are in deep remission can safely reduce or stop their medication without the disease coming back. Researchers will follow 200 patients for two years, comparing those who continue their usual treatment to those who …
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New combo treatment aims to control aggressive throat cancer
Disease control Recruiting nowThis study is testing a new treatment approach for HPV16-positive throat cancer that has not been treated before. Patients first receive an immunotherapy drug (toripalimab) combined with chemotherapy to shrink the tumor. Based on how well the tumor responds, patients then undergo…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Your phone could help you quit vaping
Disease control Recruiting nowThis study is developing and testing a mobile phone app designed to help young adults quit or reduce their use of e-cigarettes (vaping). Researchers at the University of Chicago are recruiting 46 people aged 18-26 who vape frequently and want to cut back. The goal is to see if th…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Smart knee implants track recovery from home, could reduce doctor visits
Disease control Recruiting nowThis study is testing if a 'smart' knee implant that tracks movement at home can help people recover better after knee replacement surgery. Researchers want to see if this remote monitoring can safely reduce the number of follow-up doctor visits needed. They will also check if wh…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Blood test could personalize cancer treatment, reduce chemo side effects
Disease control Recruiting nowThis study is testing a new approach for treating advanced head and neck cancer that has returned or spread. Researchers want to see if using a simple blood test to measure tumor DNA can help decide when to add short bursts of chemotherapy to standard immunotherapy. The goal is t…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Surgeons test Patient's own tissue as 'Living Patch' for tough hernias
Disease control Recruiting nowThis study is testing a new surgical technique called PoRSHA for repairing large or recurring paraesophageal hernias. The technique uses a flap of the patient's own abdominal wall tissue to reinforce the repair, aiming to make it stronger and more durable than standard methods. R…
Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Shorter test for bladder device could mean quicker relief
Disease control Recruiting nowThis study is testing if a shorter 3-day test period works as well as the standard 7-day test for a bladder control device. The device, called sacral neuromodulation, helps women with overactive bladder symptoms like sudden urges and frequent urination. Researchers want to see if…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Could cancer patients get fewer treatments?
Disease control Recruiting nowThis study is testing if two cancer drugs (nivolumab and pembrolizumab) can be given less often while still working effectively. It will compare the standard dosing schedule to a new, less frequent schedule in adults with advanced or metastatic cancer. The main goal is to see if …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
ICU drug showdown: can new combo calm racing hearts and save lives?
Disease control Recruiting nowThis study aims to find out if using the blood pressure drugs phenylephrine and vasopressin is better than the standard drugs norepinephrine and epinephrine for adults in the ICU with shock. The main goal is to see if the new drug combination causes fewer dangerous fast heart rhy…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Nerve zapper for sleep apnea may also fight diabetes and heart disease
Disease control Recruiting nowThis study is testing if an implanted nerve stimulator used to treat sleep apnea can also improve blood sugar control and reduce risk factors for heart disease. It will involve 30 adults with moderate-to-severe sleep apnea who cannot use the standard CPAP mask therapy. Researcher…
Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Cell transplant offers hope to end dangerous blood sugar crashes
Disease control Recruiting nowThis study is testing the safety of transplanting insulin-producing cells into adults with severe, hard-to-control Type 1 diabetes. The goal is to help the body better manage blood sugar levels and reduce dangerous episodes of very low blood sugar. Researchers are giving cells fr…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Radiation boost added to standard care in fight against aggressive lung cancer
Disease control Recruiting nowThis study is testing if adding a short, intense course of targeted radiation to standard immunotherapy and chemotherapy helps people with extensive-stage small cell lung cancer live longer without their cancer getting worse. It is for adults newly diagnosed with this aggressive …
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New 'Wiggle Rod' tested to heal broken legs faster
Disease control Recruiting nowThis study is testing if a new type of surgical rod that allows tiny, controlled movement at the break helps broken shin bones heal better than a standard, rigid rod. Researchers will randomly assign 372 adults with unstable tibia fractures to receive one of the two rod types. Th…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New program aims to break down barriers to HIV care and jobs for formerly incarcerated
Disease control Recruiting nowThis study is testing two support programs to help people who have been involved with the justice system access HIV care, prevention services like PrEP, and employment. Researchers want to see if adding an employment navigator and small financial incentives to a basic health navi…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Radiation precision test: can smaller margins fight brain tumors with fewer side effects?
Disease control Recruiting nowThis study compares two approaches to radiation treatment for brain tumors that have spread from other cancers. Researchers want to see if using no extra margin around the tumor (0 mm) works as well as the standard 2 mm margin at keeping tumors from growing back. The goal is to c…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
New hope for nigerian women with aggressive breast cancer
Disease control Recruiting nowThis study is testing a targeted cancer treatment approach for Nigerian women with HER2-positive breast cancer. Participants receive a combination of targeted drugs and chemotherapy both before and after surgery. The research aims to see how effective and safe this treatment is f…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Heated chemo bath tested to prime stomach cancer for newer treatments
Disease control Recruiting nowThis study is testing a procedure called HIPEC, where heated chemotherapy is washed directly into the abdomen during surgery, for people with stomach cancer that has spread to the abdominal lining. The main goal is to see if this treatment makes the cancer cells more visible to t…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New drug duo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of two drugs, ivosidenib and ruxolitinib, when used together. It is for adults with advanced blood cancers (called myeloproliferative neoplasms) that have a specific genetic change (IDH1 mutation). The main goal is to see…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New GERD surgery could free millions from daily medications
Disease control Recruiting nowThis study is testing whether a simpler surgical procedure called hiatal closure can effectively control GERD symptoms. Researchers are enrolling 40 adults with early-stage GERD to see if closing the opening in the diaphragm alone (without additional wrapping procedures) can stop…
Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New Triple-Threat attack on tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of three drugs for people with advanced head and neck cancer that has returned or spread. The main goal is to find the safest and most effective dose of the new drug, Zanzalintinib, when given with two existing cancer drugs. Res…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC
-
Quick finger prick test for common parasite under study
Diagnosis Recruiting nowThis study is testing a new, quick finger prick test to see if someone has a current or past Toxoplasma infection. Researchers will compare the results of this new test to a standard lab test to see if it's accurate. The goal is to see if this easier test could be used in clinics…
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Apr 01, 2026 14:55 UTC
-
Hospital study aims to spot kidney failure before it happens
Diagnosis Recruiting nowThis study aims to improve the early detection of serious kidney injury in hospitalized adults. Researchers will test whether adding simple blood and urine tests to a computer's risk prediction score makes it more accurate. They plan to enroll 800 patients at high risk for kidney…
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
AI assistant for prostate cancer detection shows promise
Diagnosis Recruiting nowThis study is testing new computer software designed to help doctors better analyze prostate MRI scans. The software creates detailed maps showing areas most likely to contain cancer, which could help guide biopsy procedures more accurately. Researchers will compare the software'…
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Could a simple stool test replace dozens of colonoscopies for High-Risk patients?
Diagnosis Recruiting nowThis study aims to see if a simple, at-home stool test (called FIT) can be as accurate as colonoscopy for detecting colorectal cancer in people with Lynch syndrome. Lynch syndrome is a genetic condition that greatly increases the risk of colon cancer, requiring frequent colonosco…
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Painless test could spot deadly ALS years earlier
Diagnosis Recruiting nowThis study is testing whether a simple, painless measurement of muscle activity can help doctors diagnose ALS (amyotrophic lateral sclerosis) earlier and more accurately. Researchers will use surface electrodes on the skin to measure how two muscles work together during a simple …
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC
-
New system aims to find hidden PTSD cases in chicago
Diagnosis Recruiting nowThis study is testing a new system to help primary care clinics better identify and manage Post-Traumatic Stress Disorder (PTSD). It will involve screening 17,000 adult patients in Chicago clinics, especially in areas with high rates of trauma. The goal is to see if using patient…
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
MRI scans aim to catch deadly prostate cancer earlier in High-Risk men
Diagnosis Recruiting nowThis study is testing whether MRI scans can find aggressive prostate cancers earlier and more often in men at high risk for the disease. Researchers will compare MRI results in high-risk men to those without known risk factors over 15 years. The goal is to improve early detection…
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
New research aims to solve mystery of joint replacement infections
Diagnosis Recruiting nowThis study aims to help doctors better identify infections when bones break around hip or knee replacements. Researchers will analyze lab tests from 200 patients to understand how often infections occur and what factors predict them. The goal is to create clearer guidelines for d…
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
New scan could spot prostate Cancer's return sooner
Diagnosis Recruiting nowThis study is testing if adding a special scan called a PSMA PET to the usual MRI can better detect if prostate cancer returns in men who have had focal therapy. Researchers will follow 62 men for about a year after their treatment to compare how well the two scans find returning…
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 23, 2026 15:15 UTC
-
New surgery aims to stop debilitating swelling before it starts
Prevention Recruiting nowThis study is testing a new surgical technique called Immediate Lymphatic Reconstruction (ILR). The goal is to prevent lymphedema, a painful and chronic swelling of the arm that can occur after breast cancer surgery. During the initial cancer operation, surgeons will try to recon…
Sponsor: University of Chicago • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC
-
Chicago launches High-Tech hunt for hidden breast cancer in At-Risk women
Prevention Recruiting nowThis study aims to find better ways to catch breast cancer early in women who are at high genetic risk. Researchers will test whether shorter, faster MRI scans work as well as traditional full-length MRIs for regular monitoring. The study will create a registry of 400 high-risk w…
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
Can a simple video stop deadly infections for home IV patients?
Prevention Recruiting nowThis study is testing if an educational video can help prevent dangerous bloodstream infections in adults who are new to receiving liquid nutrition through a home IV line. Researchers will see if watching the video, which teaches safe catheter handling, leads to fewer infections …
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 30, 2026 14:34 UTC
-
New push to close HIV prevention gap for southern women
Prevention Recruiting nowThis study aims to help more women at risk for HIV get access to preventive medication (PrEP) at community health clinics. It will test four strategies—training doctors, educating patients, improving clinic computer systems, and providing patient navigation—at 12 clinics in the S…
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC
-
Heart surgery breakthrough? new patch could stop dangerous Post-Op heart rhythms
Prevention Recruiting nowThis study is testing whether applying a special patch soaked with a heart rhythm medicine directly to the heart during surgery can prevent a common and serious complication called atrial fibrillation. The research involves 63 adults having open-heart bypass or valve surgery. Doc…
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC
-
Can a 3-Week diet before surgery stop colon cancer from coming back?
Prevention Recruiting nowThis study is testing if a special high-fiber, low-fat diet given for 21 days before colon cancer surgery can change the gut's bacteria and environment to help prevent the cancer from returning or spreading. Researchers will provide all meals and track participants' health for up…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
New surgery aims to stop debilitating arm swelling before it starts
Prevention Recruiting nowThis study is testing a new surgical technique called Immediate Lymphatic Reconstruction (ILR). The procedure is done during breast cancer surgery to try to prevent a painful, chronic side effect called lymphedema, which causes severe arm swelling. Researchers will measure arm si…
Sponsor: University of Chicago • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
Can a quick freeze take the sting out of needles?
Symptom relief Recruiting nowThis study is testing whether a common 'freeze spray' used to numb the skin actually helps reduce pain and anxiety for patients getting steroid injections for joint and tendon problems like arthritis or carpal tunnel. Researchers will enroll 300 adults getting their first injecti…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Apr 01, 2026 21:41 UTC
-
Can spiritual support ease the leukemia journey?
Symptom relief Recruiting nowThis study is testing whether adding guided spiritual care sessions to standard hospital care can help adults with acute leukemia feel better during their treatment. Researchers will enroll 70 hospitalized patients and randomly assign them to receive either the special spiritual …
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Ear seeds for surgery strength? study tests ancient technique on modern patients
Symptom relief Recruiting nowThis small pilot study is testing whether a simple ear acupressure technique can boost the benefits of standard pre-surgery exercise programs (prehabilitation) for people facing major lung surgery. Researchers will give 40 participants small seeds to press on specific points of t…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Can video lessons cut hospital trips for cancer patients?
Symptom relief Recruiting nowThis study is testing whether watching educational videos before bladder removal surgery helps older patients recover better. Researchers want to see if learning strategies from the videos can reduce problems like difficulty moving, medication issues, and poor quality of life aft…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Ice vs. machine: which cools pain better after hand surgery?
Symptom relief Recruiting nowThis study compares two common methods for managing pain after carpal tunnel release surgery. Researchers want to see if a machine that provides continuous cooling works better than traditional ice packs. They will measure pain levels and hand function in 128 adults recovering fr…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
Laughing gas tested as new hope for fibromyalgia sufferers
Symptom relief Recruiting nowThis study is testing whether nitrous oxide, commonly known as laughing gas, can help reduce the chronic pain of fibromyalgia. Researchers are comparing two 60-minute sessions of inhaled nitrous oxide to a placebo (oxygen-air mixture) in 50 adults with fibromyalgia. The goal is t…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
New program aims to calm Women's dementia fears during menopause
Symptom relief Recruiting nowThis study is creating and testing a short, personalized counseling program for women going through menopause who have a higher risk of dementia. The goal is to help them manage their fears and learn better ways to cope. Researchers will first talk to women in focus groups, then …
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
New nerve block tested to ease agony after knee surgery
Symptom relief Recruiting nowThis study aims to find a better way to manage pain after surgery for a broken knee (tibial plateau fracture). Researchers are comparing the standard pain injection around the surgical cut to a different injection that numbs a nerve controlling a larger knee area. The study will …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Coffee for kids? caffeine tested to speed recovery from MRI sedation
Symptom relief Recruiting nowThis study is testing whether giving caffeine can help children wake up faster and feel more alert after being sedated for an MRI scan. Researchers will enroll 100 children aged 3 to 12 and randomly give them either caffeine or a placebo (inactive substance) after their MRI. The …
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
New approach to ease agony after kidney stone surgery
Symptom relief Recruiting nowThis study is testing whether putting a numbing medication (bupivacaine) into the bladder right after kidney stone surgery can reduce pain and discomfort. Researchers will compare the medication to a saltwater placebo in 116 adults having this common procedure. The main goal is t…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
New surgical hope for inoperable lung cancer patients
Symptom relief Recruiting nowThis study is testing whether a surgery to remove part of the lung lining can help reduce symptoms and improve quality of life for people with advanced pleural mesothelioma that cannot be fully removed. Researchers will follow 30 participants for about 2 years after surgery to tr…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Hospital program aims to empower kidney patients before dialysis
Knowledge-focused Recruiting nowThis study is testing whether a 12-week education and support program helps hospitalized African American adults with advanced chronic kidney disease. The program provides information about kidney disease and treatment options, along with follow-up phone calls and text messages f…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC
-
Scientists build 'Library' of cancer samples to unlock future treatments
Knowledge-focused Recruiting nowThis study aims to collect and store tissue and blood samples from patients undergoing surgery or biopsy for various gastrointestinal cancers. Researchers will create a database and tissue samples to help future studies understand how these cancers develop and behave. The goal is…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists probe hidden link between kidney stones and belly fat
Knowledge-focused Recruiting nowThis study aims to understand the connection between kidney stones, insulin resistance, and inflammation. Researchers will compare 20 people who have had calcium kidney stones with 20 healthy people. They will measure body fat, take blood and urine samples, and analyze them to se…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test if common pill alters kidney chemistry to prevent painful stones
Knowledge-focused Recruiting nowThis study aims to understand how a supplement called potassium citrate affects two natural body chemicals, oxalate and citrate, which are linked to kidney stone formation. Researchers will give the supplement to 24 people—half with a history of kidney stones and half without—and…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists seek clues in scarred lungs
Knowledge-focused Recruiting nowThis study aims to understand what causes pulmonary fibrosis, a serious disease that scars the lungs. Researchers will collect and examine lung tissue from patients who are receiving a lung transplant, both with and without the disease. By comparing these tissues at a cellular le…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists probe why a key drug fails to stop dangerous Post-Birth bleeding
Knowledge-focused Recruiting nowThis study aims to understand why the standard drug oxytocin sometimes fails to prevent heavy bleeding after a C-section. Researchers will measure how the drug moves through the body and how its levels relate to the strength of uterine contractions in 100 women having planned C-s…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Doctors' marathon shifts may weaken their Body's defenses
Knowledge-focused Recruiting nowThis study aims to understand how the sleep deprivation from 24-hour hospital shifts affects the immune systems of surgery residents. Researchers will recruit 60 healthy residents to measure changes in their immune cells and inflammation before and after their long shifts. The go…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Quick MRI scan may reveal hidden health risks in liver patients
Knowledge-focused Recruiting nowThis study aims to see if a special MRI scan that measures muscle health can help predict which liver disease patients are at higher risk for serious health problems or death. Researchers will add an 8-10 minute scan to the routine MRIs of 1,200 patients at the University of Chic…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Your genes could guide your surgery pain meds
Knowledge-focused Recruiting nowThis study is testing whether giving doctors genetic information about patients helps them choose safer and more effective pain medications during and after surgery. Researchers are enrolling 1900 adults having elective surgery at the University of Chicago. They will compare outc…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists probe why hospitalized Patients' own gut bacteria turn deadly
Knowledge-focused Recruiting nowThis study aims to understand why a dangerous bacteria called Pseudomonas aeruginosa often grows in the guts of critically ill patients and makes their condition worse. Researchers will collect stool samples from 100 hospitalized patients to analyze how the patient's body chemist…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Scientists hunt for long COVID clues in gut bacteria
Knowledge-focused Recruiting nowThis study aims to understand how COVID-19 changes gut bacteria in people with long COVID symptoms. Researchers will collect stool and blood samples from 400 people with and without long COVID to identify bacterial differences. The goal is to learn how these changes might contrib…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test if your diet determines your kidney stone fate
Knowledge-focused Recruiting nowThis study aims to learn how two common food compounds, oxalate and citrate, influence a person's chance of forming kidney stones. Researchers will give 50 participants (25 with a history of stones and 25 without) a single dose of oxalate and then measure changes in their urine a…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Scientists probe why celiac disease hits people differently
Knowledge-focused Recruiting nowThis study aims to understand why celiac disease symptoms and gut damage vary so much between people. Researchers will observe 220 adults, including some who eat gluten and some on a gluten-free diet, to see how their bodies react. The goal is to gather information that could lea…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Researchers test new ways to see inside reconstructed breasts
Knowledge-focused Recruiting nowThis study aims to find the best way to measure changes after fat grafting surgery for breast or chest wall reconstruction. It will enroll 15 adults who are already planning to have this procedure. Researchers will use different types of imaging, like photos and MRI scans, taken …
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Computer aims to predict brain crises before they cause lasting damage
Knowledge-focused Recruiting nowThis study is testing a computer system designed to predict dangerous pressure and oxygen changes in the brain of patients with severe traumatic brain injury (TBI) before they happen. About 120 patients will have their brain monitor data collected to see if the system's predictio…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC
-
Scientists track heart and brain data to predict recovery from severe injuries
Knowledge-focused Recruiting nowThis study aims to understand how a patient's heart function relates to their recovery after a severe traumatic brain injury or brain bleed. Researchers will observe 50 adult patients already receiving standard care, using a non-invasive monitor to collect heart and brain pressur…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Scientists hunt for genetic roots of heart and muscle disorders
Knowledge-focused Recruiting nowThis study aims to find the specific genes that cause inherited heart and muscle diseases like cardiomyopathy and muscular dystrophy. Researchers will analyze DNA from up to 2,000 patients and their family members who have these conditions. The goal is to better understand the ge…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC
-
Scientists probe hidden link between sleep apnea and diabetes
Knowledge-focused Recruiting nowThis study aims to understand how sleep apnea contributes to the development of diabetes. Researchers will study 300 people who have both prediabetes and sleep apnea under different lab conditions to see how their bodies process sugar. The goal is to learn the underlying biologic…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Scientists probe hidden link between sleep breathing and diabetes control
Knowledge-focused Recruiting nowThis study aims to understand how obstructive sleep apnea (a condition where breathing stops and starts during sleep) affects blood sugar levels in adults with Type 1 diabetes. Researchers will observe 40 adults who have both conditions, using continuous glucose monitors to track…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Massive study tracks new prostate cancer treatment
Knowledge-focused Recruiting nowThis study is creating a large database to track the long-term results and side effects of prostate ablation, a minimally invasive treatment for prostate cancer. It will follow 3,000 men who have had or will have this procedure as part of their regular care. The goal is to gather…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Weight loss drug could protect brain function in chronic illness
Knowledge-focused Recruiting nowThis study is testing whether a weight loss medication called liraglutide (Saxenda) affects brain health markers in people with multiple sclerosis, long COVID, or leukemia in remission who also have obesity and cognitive problems. Researchers will measure changes in a protein cal…
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Researchers test new ways to boost minority participation in cancer trials
Knowledge-focused Recruiting nowThis study is testing different outreach methods to see which ones work best to increase enrollment of African American patients in early-phase cancer treatment trials. It will enroll both patients and their doctors to receive different recruitment approaches or no special outrea…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Scientists build heart disease 'Library' from surgery patients
Knowledge-focused Recruiting nowThis study is collecting blood and tissue samples from 500 patients undergoing heart surgery to create a research biobank. The goal is to help scientists better understand how heart diseases develop and progress. This knowledge could lead to improved treatments in the future, but…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC
-
Doctors test which tool works better for removing blood clot traps
Knowledge-focused Recruiting nowThis study compares two common tools doctors use to remove temporary blood clot filters from patients' veins. Researchers want to see if one method works better than the other by looking at success rates, procedure time, and safety. The study will help doctors choose the best app…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC
-
Could your genes guide your meds? new study aims for safer prescriptions
Knowledge-focused Recruiting nowThis study is testing a new system that gives doctors genetic information about their African American patients to help them prescribe medications more safely and effectively. Researchers will see if this system is useful in hospitals and if it specifically improves outcomes for …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC
-
DNA tests aim to predict your best medications
Knowledge-focused Recruiting nowThis study is testing whether genetic information can help doctors choose safer and more effective medications for their patients. Researchers will collect DNA samples from 1,200 adults receiving routine care at the University of Chicago Medical Center. They will track whether do…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC
-
Blood test could predict Cancer's return after radiation
Knowledge-focused Recruiting nowThis study is testing a blood test to see if it can detect HPV virus DNA in people with anal or cervical cancer before, during, and after they receive standard radiation treatment. Researchers want to learn if the results of this blood test can help predict whether the cancer mig…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC
-
Can a trusted Friend's story online change minds about vaccines?
Knowledge-focused Recruiting nowThis study is testing a new way to share trustworthy health information online. Researchers are training community health workers in seven high-risk neighborhoods to post personal stories about flu and COVID-19 protection on their social media. The goal is to see if these persona…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC